Pay in 4 interest-free payments of $5.40 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
For retatrutide, the safety database is smaller because the compound is still in Phase 3 trials
No safety screening: Semaglutide is contraindicated in certain patients
The SYNERGY-NASH trial showed 74% MASH resolution vs 13% for placebo
Long-term disease history, clinical symptoms, health status, and healthcare utilization in patients suffering from Lambert Eaton myasthenic syndrome: results of a patient interview survey in Germany
US$ 22.09
US$ 21.04
US$ 27.51
US$ 28.79
US$ 25.79
